Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-30

Clinical Trial Update: The Effects of Treatment With Vemurafenib on the Immune System in Advanced Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the effects of vemurafenib on the immune system in advanced melanoma; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vemurafenib (vemurafenib)

Snippet

Sponsor: Philip Friedlander | Conditions: Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2020-09-30